• Latest Posts

Belgian Antibody Proves Effective to Treat Myasthenia Gravis

More News! 23 Aug 2017

Dutch Biotech could treat Dyslipidemia with Belgian Nanobody

More News! 20 Jun 2017

Belgian Llama Antibody Developer gets Second Preclinical Milestone from Danish Pharma

UPDATE: Argenx’s IPO soars to over €100M to prove itself in Phase II

Infographics 13 Feb 2017

Infographic: What’s in Europe’s Immuno-oncology Pipeline?

How is European Immuno-Oncology fighting Blood Cancer?


World’s Best Journal in Medicine Publishes on Phase II Llama Antibodies

When the Llama met the Lion: Antibodies Unlock Milestone Payment for Skin Disease

For when it actually is Lupus: New Autoimmune Crisis Drug reaches Human Trials

Forbion Capital Partners: a Leading European Biotech VC is rising!